Caixin
BUSINESS & TECH

Genome Giant Disputes Financial, Legal Rumors

BGI admitted that it is currently involved in a lawsuit, but said it is as a third party rather than as the plaintiff or defendant, so it is not legally obligated to disclose information about the case. Photo: Visual China
BGI admitted that it is currently involved in a lawsuit, but said it is as a third party rather than as the plaintiff or defendant, so it is not legally obligated to disclose information about the case. Photo: Visual China

BGI Genomics Co., one of China’s largest genome sequencing companies, has responded to reports about a discrepancy in its financial data and denied a rumor that it was embroiled in a lawsuit.

The Shenzhen-listed biotechnology firm published a letter late Monday in response to inquiries from the Shenzhen Stock Exchange, after Chinese media outlets said they had found inconsistent data in two investment prospectuses for the company’s product sales.

ladingImg
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
Copyright © 2017 Caixin Global Limited. All Rights Reserved.